Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Aust Dent J ; 59(2): 165-71, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24861390

ABSTRACT

BACKGROUND: Localized aggressive periodontitis (LAgP) is an infectious periodontal disease which generally affects young people. Recent data suggest the involvement of different bacterial species in different populations. The causative bacterial species in Israel has never been identified despite a high prevalence of LAgP in this population. The objectives of this study were to characterize the bacterial microbiota of periodontal pockets within an Israeli LAgP population who were also clinically assessed. METHODS: Twenty-one LAgP patients (test) and 12 chronic periodontitis patients (control) were examined. Bacterial samples were collected from periodontal pockets and analysed by both culture and polymerase chain reaction techniques. Mann-Whitney U test and chi-square test were used to compare results between the groups. RESULTS: Higher levels of Parvimonas micra (>10(6) ), Aggregatibacter actinomycetemcomitans (>10(5) ), Fusobacterium nucleatum/F. periodonticum (>10(6) ), and Tannerella forsythia (levels of 10(5) to 10(6) bacteria) were detected in the LAgP group compared to the control (p < 0.05), while levels of Porphyromonas gingivalis and Prevotella intermedia were higher in the CP group. CONCLUSIONS: The characteristic periodontal bacterial flora of LAgP patients in Israel is mainly comprised of P. micra, A. actinomycetemcomitans, F. nucleatum/F. periodonticum and T. forsythia. Similar population based studies of each population will improve the quality of treatment of LAgP when individual sampling is not possible.


Subject(s)
Aggressive Periodontitis/microbiology , Periodontal Pocket/microbiology , Adolescent , Adult , Aggregatibacter actinomycetemcomitans/isolation & purification , Aggressive Periodontitis/pathology , Chi-Square Distribution , Child , Chronic Periodontitis , Cohort Studies , Dental Plaque/microbiology , Female , Fusobacterium/isolation & purification , Fusobacterium nucleatum/isolation & purification , Humans , Israel , Male , Middle Aged , Polymerase Chain Reaction , Porphyromonas gingivalis/isolation & purification , Prevotella intermedia/isolation & purification , Statistics, Nonparametric , Young Adult
2.
Refuat Hapeh Vehashinayim (1993) ; 25(1): 24-33, 82, 2008 Jan.
Article in Hebrew | MEDLINE | ID: mdl-18661799

ABSTRACT

Pregnancy complications, especially low birth weight (defined as birth weight less than 2.500 kilograms (kg)), pre-term delivery (less than 37 weeks) and pre-ecclampsia (elevated maternal blood pressure), continue to be a significant public health issue in both developed and developing countries. Recent data indicate that periodontal disease might confer risk for several systemic disorders. The relationship between periodontal diseases in pregnancy and obstetric complications has been increasingly investigated, showing inconclusive results. The purpose of this study is to review the current literature regarding the influence of periodontal status on pregnancy outcome, including the effect of periodontal treatment. Further research in this area is required, particularly with respect to the effect of population differences on this potential association between periodontal diseases and pregnancy complications as well as on the exact mechanism of this association. Since pregnancy tends to influence periodontal status, and considering the potential reported relation between periodontal disease and pregnancy complications, careful periodontal diagnosis and treatment before as well as during pregnancy is warranted.


Subject(s)
Periodontitis , Pregnancy Complications , Female , Humans , Infant, Low Birth Weight , Infant, Newborn , Periodontitis/complications , Periodontitis/therapy , Pre-Eclampsia/etiology , Pregnancy , Premature Birth/etiology
3.
J Periodontol ; 72(9): 1236-40, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11577956

ABSTRACT

BACKGROUND: Cyclosporin A (CsA) is widely used to prevent liver transplantation failure. CsA-induced gingival overgrowth is a common side effect. However, the effect of cirrhotic liver disease, liver transplantation, and immunosuppressive therapy on the periodontium is yet unclear. The aim of the present cross-sectional study was to examine the effect of liver cirrhosis, transplantation, and immunosuppressive therapy on the periodontium. METHODS: The experimental group (LC) consisted of 13 liver cirrhosis patients. A second experimental group (PT) included 24 patients, post-liver transplantation, receiving immunosuppressive therapy. Seventeen healthy subjects formed a control group. The Ramfjord index teeth were recorded for plaque index (PI), gingival index (GI), probing depth (PD), clinical attachment level (CAL), and gingival overgrowth (GO). RESULTS: Mean PI and mean GI for the LC, PT, and C groups were not statistically different (P >0.05). Mean PD for the LC (3.32+/-0.24 mm) and PT group (3.41+/-0.13 mm) was significantly higher (P = 0.0001, ANOVA) compared to the C group (2.45+/-0.16 mm). Likewise, CAL for the LC (4.89+/-0.47 mm) and PT group (4.68+/-0.47 mm) was significantly higher (P = 0.001, ANOVA) than the C group (2.78+/-0.23 mm). Patients in the PT group exhibited the greatest mean GO scores (0.88+/-0.09) compared to the LC group (0.37+/-0.07) and the C group (0.09+/-0.02). All 3 groups were significantly different from each other (P = 0.0001) despite great variability within the groups. GO in the CsA-treated patients (1.1+/-0.09) was significantly higher (P = 0.0001) than in those treated with tacrolimus (0.57+/-0.1). CONCLUSIONS: Liver cirrhosis patients demonstrated greater pocketing and attachment loss compared to healthy matched controls. These same differences were observed in patients post-transplantation. Gingival overgrowth occurred as a result of the immunosuppressive therapy with CsA, while to a lesser degree with tacrolimus. Replacement of CsA by tacrolimus in patients manifesting gingival overgrowth might be recommended whenever possible to overcome this problem.


Subject(s)
Cyclosporine/adverse effects , Gingival Hyperplasia/etiology , Immunosuppressive Agents/adverse effects , Liver Cirrhosis/complications , Liver Transplantation/adverse effects , Tacrolimus/adverse effects , Analysis of Variance , Female , Humans , Male , Middle Aged , Statistics, Nonparametric
5.
J Periodontol ; 71(4): 650-6, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10807132

ABSTRACT

Gingival hyperplasia appears in 8% to 85% of patients treated with cyclosporine. Most studies show an association between oral hygiene status and the prevalence and severity of this gingival overgrowth. Thus, besides attempting to substitute this drug with another whenever possible, treatment usually involves maintenance of strict oral hygiene coupled with scaling and root planing and removal of iatrogenic factors. Sometimes a second treatment phase involving periodontal surgery is necessary. Cyclosporine-induced gingival overgrowth has been mainly described in post-organ transplant patients. The present case describes, for the first time, a severe form of cyclosporine-induced gingival overgrowth arising in a 15 year-old male with pemphigus vulgaris. Periodontal treatment included oral hygiene and scaling and root planing under local anesthesia. There was a significant reduction in gingival enlargement, as well as a reduction in plaque levels and inflammation. Cessation of drug administration, combined with continuous periodontal treatment, brought further improvement. This successful conservative treatment of cyclosporine-induced gingival overgrowth in a pemphigus vulgaris patient suggests that early diagnosis and comprehensive treatment of these lesions may yield good response and reduce the need for periodontal surgery.


Subject(s)
Cyclosporine/adverse effects , Gingival Hyperplasia/chemically induced , Immunosuppressive Agents/adverse effects , Pemphigus/drug therapy , Adolescent , Dental Plaque/prevention & control , Dental Scaling , Follow-Up Studies , Gingival Hemorrhage/prevention & control , Gingival Hyperplasia/therapy , Gingivitis/prevention & control , Humans , Male , Oral Hygiene , Patient Compliance , Prevalence , Root Planing , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...